Abstract
Background
Although mortality after liver resection has declined, posthepatectomy liver failure (PHLF) remains a major cause of operative mortality. To date there is not consensus on a definition for PHLF. However, there have been many efforts to define PHLF causing operative mortality. In the present study we sought to identify early predictors of death from irreversible PHLF.
Materials and methods
We retrospectively analyzed the medical records of 359 patients with hepatocellular carcinoma who underwent liver resection between March 2000 and December 2010. Various biochemical parameters from postoperative days (POD) 1, 3, 5, and 7 were analyzed and compared with the “50–50” criterion.
Results
Operative mortality was 4.7 %. Prothrombin time (PT) <65 % and bilirubin ≥38 μmol/L on POD 5 showed the only significant difference as compared with “50–50” criterion. The new combination of bilirubin level and the international normalized ratio showed higher sensitivity, area under the curve, as well as similar accuracy (sensitivity 78.6 vs. 28.6 %; p = 0.002; area under the curve 0.8402 vs. 0.6396; p = 0.00176; accuracy 88.6 vs. 93.4 %; p = 0.090). Multivariate analysis revealed the combination of PT <65 % and bilirubin ≥38 μmol/L on POD 5 to be the only independent predictive factor of mortality (odds ratio, 82.29; 95 % confidence interval 8.69–779.64; p < 0.001).
Conclusions
In patients with chronic liver disease who will undergo liver resection the combination of PT <65 % and bilirubin ≥38 μmol/L on POD 5 may be a more sensitive predictor than the “50–50” criterion of mortality from PHLF. Although it needs to validated by prospective study, this measure may be applied to select patients receiving artificial liver supports or liver transplantation.
Similar content being viewed by others
References
Foster JH, Berman MM (1977) Solid liver tumors. Major Probl Clin Surg 22:1–342
Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46
Cohnert TU, Rau HG, Buttler E et al (1997) Preoperative risk assessment of hepatic resection for malignant disease. World J Surg 21:396–400. doi:10.1007/PL00012260 discussion 401
Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206 discussion 1206
Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg 236:397–406 discussion 406–397
Sitzmann JV, Greene PS (1994) Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 219:13–17
Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971
Dinant S, De Graaf W, Verwer BJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692
Farges O, Malassagne B, Flejou JF et al (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215
Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7
Kawano Y, Sasaki A, Kai S et al (2008) Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 15:1670–1676
McCormack L, Petrowsky H, Jochum W et al (2007) Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 245:923–930
Mullen JT, Ribero D, Reddy SK et al (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862
Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724
Banares R, Nevens F, Larsen FS et al (2010) Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AOCLF). J Hepatol 52:S459–S460
Hassanein TI, Schade RR, Hepburn IS (2011) Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care 17:195–203
Jalan R, Sen S, Williams R (2004) Prospects for extracorporeal liver support. Gut 53:890–898
Mitzner SR, Stange J, Klammt S et al (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277–286
Paugam-Burtz C, Janny S, Delefosse D et al (2009) Prospective validation of the “fifty–fifty” criteria [sic] as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249:124–128. doi:10.1097/SLA.0b013e31819279cd
Balzan S, Belghiti J, Farges O et al (2005) The “50–50 criteria” [sic] on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828 discussion 828–829
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
Truty MJ, Vauthey JN (2010) Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol 17:1219–1225
Garcea G, Maddern GJ (2009) Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 16:145–155
Min S, Kim S, Lee S et al (2011) The effect of preconditioning on liver regeneration after hepatic resection in cirrhotic rats. Clin Mol Hepatol 17:139–147
Farges O, Belghiti J, Kianmanesh R et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208–217
Martin RCG, Jarnagin WR, Fong Y et al (2003) The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: Is there a standard for transfusion? J Am Coll Surg 196:402–409
Schindl MJ, Redhead DN, Fearon KCH et al (2005) The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54:289–296
Vauthey JN, Pawlik TM, Abdalla EK et al (2004) Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239:722–730 discussion 730–722
Heemann U, Treichel U, Loock J et al (2002) Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 36:949–958
Acknowledgments
This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084120).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, S.H., Kang, D.R., Lee, J.G. et al. Early Predictor of Mortality due to Irreversible Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. World J Surg 37, 1028–1033 (2013). https://doi.org/10.1007/s00268-013-1959-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-013-1959-z